As of Apr 21
| +0.10 / +0.24%|
The 16 analysts offering 12-month price forecasts for Imperva Inc have a median target of 52.50, with a high estimate of 56.00 and a low estimate of 35.00. The median estimate represents a +23.97% increase from the last price of 42.35.
The current consensus among 19 polled investment analysts is to Buy stock in Imperva Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.